Moderna to charge Rs 1855-Rs 2755 for COVID-19 vaccine: CEO

Moderna has said its experimental vaccine is 94.5 per cent effective in preventing Covid-19 based on interim data

COVID-19 Vaccine Update: Moderna to Charge Between $25 And $37 Per Dose of Its Vaccine, Says CEO

Moncef Slaoui, the head of the USA government's effort to develop a vaccine against Covid-19, said the first Americans to receive a vaccine - if all things go according to plan - could be as early as the second week of December.

"Our plan is to be able to ship vaccines to the immunization sites within 24 hours of approval" by the US Food and Drug Administration, Moncef Slaoui told CNN.

Moderna will charge governments between US$25 and US$37 (S$33.60 and S$49.70) per dose of its Covid-19 vaccine candidate, depending on the amount ordered, chief executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

The developers of the world's first vaccine against coronavirus have taken to Twitter to announce that the price of Sputnik V will be much lower than that of vaccines developed by USA pharmaceutical companies Pfizer and Moderna. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines.

"Sputnik V price will be announced next week, stay tuned!" the spokesperson said.

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. The claim made by the US-based biotechnology firm us based on interim data from a late-stage clinical trial.

It is learnt that the European Union and Moderna has been in talks for the latter's COVID-19 vaccine since July.

The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic.

Latest News